New model aims to predict lymphedema risk in breast cancer patients

NCT ID NCT07252843

Completed Knowledge-focused Sponsor: Dharmais National Cancer Center Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at 133 breast cancer patients to develop a way to predict who will get arm swelling (lymphedema) after lymph node removal surgery. Researchers examined patient characteristics, proteins, and genes to build a risk model. The goal is to help doctors identify high-risk patients early so they can take steps to prevent or manage lymphedema.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a tool that helps doctors identify which breast cancer patients are most likely to develop lymphedema after surgery, allowing for earlier monitoring or prevention.
What could go wrong: This is an observational study that only builds a prediction model; it does not test any treatment. The model may not be accurate enough for routine use and needs further validation in larger, more diverse groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm lymphedema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LYMPHEDEMA ARM

Contacts and locations

Locations

Dharmais Cancer Hospital

Jakarta, DKI Jakarta, 11420, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.